콘텐츠로 건너뛰기
Merck
  • Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.

Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.

Early human development (2009-02-06)
Annette Queisser-Luft
초록

Between 1977 and 2005, 28 cases of potential links between maternal dydrogesterone use during pregnancy and congenital birth defects were reported. The types of defects were very diverse, with no evidence of a pattern of abnormalities. The data do not provide evidence for congenital malformations associated with dydrogesterone use.

MATERIALS
제품 번호
브랜드
제품 설명

Dydrogesterone, European Pharmacopoeia (EP) Reference Standard